Gentian Diagnostics ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-5.02	25.67	20.06	-10.37	-23.62	-24.79
Depreciation & Amortization	9.04	9.12	8.96	9.57	10.24	7.35
Stock-Based Compensation	3.07	3.31	2.58	3.04	3.35	4.63
Other Adjustments	30.24	-	-	5.58	-	-
Change in Receivables	-7.13	9.5	-11.72	-1.2	-3.55	1.12
Changes in Inventories	-1.84	-8.2	-8.83	2.69	-8.77	-8.9
Changes in Accounts Payable	-2.27	-4.09	2.84	-0.88	-0.53	-0.83
Changes in Other Operating Activities	-6.84	7.29	-0.44	7.02	8.92	-5.63
Operating Cash Flow	19.28	42.59	13.46	15.46	-13.95	-27.05
Operating Cash Flow Growth	-3.09%	216.49%	-12.95%	-	-	-
Capital Expenditures	-1.01	-1.21	-1.38	-0.96	-8.64	-1.02
Purchases of Intangible Assets	-5.39	-9.55	-9.57	-3.53	-6.03	-11.79
Purchases of Investments	-	-	-	-0.39	-	-
Investing Cash Flow	-6.39	-10.76	-10.95	-4.88	-14.67	-12.82
Issuance of Common Stock	1.18	-	-	-	-	0.57
Net Common Stock Issued (Repurchased)	1.18	-	-	-	-	0.57
Common Dividends Paid	-9.28	-6.17	-	-	-	-
Other Financing Activities	-4.99	-4.96	-4.95	-4.6	-4.33	-3.69
Financing Cash Flow	-13.08	-11.13	-4.95	-4.6	-4.33	-3.12
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.71	0.49	-0.46	0.06	-0.4	-0.06
Net Cash Flow	-0.17	20.7	-2.44	5.98	-32.94	-42.99
Free Cash Flow	18.27	41.38	12.08	14.5	-22.59	-28.08
Free Cash Flow Growth	-55.85%	242.57%	-16.71%	-	-	-
FCF Margin	10.03%	23.45%	7.94%	10.73%	-20.18%	-28.07%
Free Cash Flow Per Share	1.18	2.67	0.77	0.94	-1.38	-1.74
Levered Free Cash Flow	-11.31	16.16	46.46	6.8	-22.39	-33.83
Unlevered Free Cash Flow	-15.2	16.05	36.66	4.34	-22.01	-31.88